Institution profile

医療法人医新会 よろずクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01F2111003 +8

Location

Prefecture
Tottori
Address
鳥取市美萩野1-118-4

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 医療法人清悠会認定再生医療等委員会
  • 患者の集いモミの木再生医療等委員会
  • 同仁会認定再生医療等委員会
  • +1

Public score

40.0/ 100

A · Review level
10.0 / 30
B · Technologies
26.5 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1203of 1736

Registered technologies
9
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 40.0
Public score →100

Registered technologies (9)

NK and immune cells 9
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対する活性化リンパ球療法NK and immune cellsClass III
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)NK and immune cellsClass III
悪性腫瘍に対するナチュラルキラー(NK)細胞療法NK and immune cellsClass III
悪性腫瘍に対する樹状細胞ワクチン療法NK and immune cellsClass III
活性化自己αβTリンパ球を用いたがん免疫細胞治療(αβT細胞療法)NK and immune cellsClass III
悪性腫瘍に対する自家培養樹状細胞を用いた樹状細胞ワクチン療法(樹状細胞(DC)ワクチン療法)NK and immune cellsClass III
GMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT<sup>®</sup>)NK and immune cellsClass III
全血採血によるGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT<sup>®</sup>Ⅱ)NK and immune cellsClass III
悪性腫瘍に対する自己活性化NK細胞療法(NK細胞療法)NK and immune cellsClass III

Certified committee for regenerative medicine

  • 医療法人清悠会認定再生医療等委員会
  • 患者の集いモミの木再生医療等委員会
  • 同仁会認定再生医療等委員会
  • 日本薬事法務学会再生医療等委員会

Public document number

  • 01F2111003
  • 01F2111004
  • 01F2111005
  • 02F2601004
  • 02F2601005
  • 02F2601006
  • 02F2410008
  • 03F2412001
  • 03F2412002
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性腫瘍に対する樹状細胞ワクチン療法Class III医療法人清悠会認定再生医療等委員会01F2111003
悪性腫瘍に対する活性化リンパ球療法Class III医療法人清悠会認定再生医療等委員会01F2111004
悪性腫瘍に対するナチュラルキラー(NK)細胞療法Class III医療法人清悠会認定再生医療等委員会01F2111005
活性化自己αβTリンパ球を用いたがん免疫細胞治療(αβT細胞療法)Class III患者の集いモミの木再生医療等委員会02F2601004
悪性腫瘍に対する自己活性化NK細胞療法(NK細胞療法)Class III患者の集いモミの木再生医療等委員会02F2601005
悪性腫瘍に対する自家培養樹状細胞を用いた樹状細胞ワクチン療法(樹状細胞(DC)ワクチン療法)Class III患者の集いモミの木再生医療等委員会02F2601006
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)Class III同仁会認定再生医療等委員会02F2410008
GMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT<sup>®</sup>)Class III日本薬事法務学会再生医療等委員会03F2412001
全血採血によるGMP準拠Alpha-GalactosylceramideとCD1d抗原提示自己樹状細胞を用いたNKT細胞標的治療(RIKEN-NKT<sup>®</sup>Ⅱ)Class III日本薬事法務学会再生医療等委員会03F2412002

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor